SCHEMBL15112575

SCHEMBL15112575

COc1nc2ccc(I)cn2c1C

nearest known ligand 0.35

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 4/20 0.35
▸ CYP11B2 P19099 4/20 0.35
▸ APP P05067 2/20 0.35
▸ DRD2 P14416 1/20 0.32
▸ DRD4 P21917 1/20 0.32
▸ DRD3 P35462 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ HTR6 P50406 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7998877 0.78 MCHR1 (0.36) CYP11B1CYP11B2APPALDH1A1SMN1; SMN2
SCHEMBL17810161 0.76 MCHR1 (0.34) CYP11B1CYP11B2APPDRD2DRD4
SCHEMBL22363049 0.75 USP7 (0.40) CYP11B1CYP11B2APP
SCHEMBL17810219 0.75 PDE10A (0.34) CYP11B1CYP11B2APPKDM4EALDH1A1
SCHEMBL15111001 0.74 APP (0.33) CYP11B1CYP11B2APP
SCHEMBL16160303 0.72 ALDH1A1 (0.36) CYP11B1CYP11B2APPKDM4EALDH1A1
SCHEMBL17810131 0.72 APP (0.32) CYP11B1CYP11B2APPALDH1A1
SCHEMBL1500061 0.72 MCHR1 (0.41) CYP11B1CYP11B2APPKDM4ESMN1; SMN2
SCHEMBL15110953 0.72 KDM4C (0.34) CYP11B1CYP11B2APPKDM4EALDH1A1
SCHEMBL12045426 0.71 HTR6 (0.50) KDM4EALDH1A1RAB9ASMN1; SMN2HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2802571-A1 BENZIMIDAZOLE DERIVATIVES AS MCH RECEPTOR ANTAGONISTS Takeda Pharmaceutical Company Limited (JP) 2014-11-19 — — EP disclosed
WO-2013105676-A1 BENZIMIDAZOLE DERIVATIVES AS MCH RECEPTOR ANTAGONISTS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-07-18 — — WO disclosed
Send feedback